Tag: cancer cells

April 12, 2017

Therapeutics Solutions Subsidiary Files IND

Therapeutics Solutions International subsidiary Emvolio filed an Investigational New Drug (IND) application for use of its StemVacs cancer immunotherapeutic in...
April 11, 2017

Propanc Biopharma: Next Wave of Cancer Technology ?

The Investing News Network had the chance to speak with James Nathanielsz, CEO of Propanc Biopharma, about what the company...
April 10, 2017

Will Cancer be Cured Under Trump?

Trump has introduced new ways to reduce funding for medical research twice–is it possible a cure for cancer will be...
April 5, 2017

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it...
March 30, 2017

Cellectar Biosciences Begins Phase II Trial

Cellectar Biosciences began a Phase II clinical study for their lead phospholipid drug conjugate CLR 131 to treat patients with...
March 29, 2017

Cyclacel Reports Fourth Quarter And 2016 Financial Results

Cyclacel Pharmaceuticals (NASDAQ:CYCC) posted its financial results for their fourth quarter and 2016.
March 29, 2017

Immunovaccine Announces Positive Data From New Study

Immunovaccine announced the first interim data from its still ongoing Phase 1b clinical study of DPX-Survivac, in combination with epacadostat...